Skip to content

AOM vs AOK: returns, risk and drawdowns compared

iShares Core Moderate Allocation ETF against iShares Core Conservative Allocation ETF, over the same 17 years (December 2008 to October 2026) with dividends reinvested.

Data updated October 2026

AOM

iShares Core Moderate Allocation ETF

10,000 became

30,577

A year on average
+6.4%
Annual volatility
7.3%
Deepest fall
−18.7%
Worst month
−6.3%

AOK

iShares Core Conservative Allocation ETF

10,000 became

25,337

A year on average
+5.3%
Annual volatility
6.1%
Deepest fall
−17.5%
Worst month
−5.8%

AOM came out ahead by 1.1 percentage points a year from December 2008 to October 2026. AOM swung more (7.3% against 6.1% a year). The correlation of monthly returns was 0.97: they moved almost in lockstep.

Growth of 10,000: AOM vs AOK

10k20k30k200920152021
AOM — iShares Core Moderate Allocation ETFAOK — iShares Core Conservative Allocation ETF

Who was ahead, and when

The gap between the two over the previous three years, at each month-end. Above zero AOM had returned more, below zero AOK. AOM was ahead in 98% of the 180 three-year periods.

0+2 pt200920152021

Annualised 3-year return of AOM minus that of AOK, in percentage points a year.

Falls from the previous high

-10%0%200920152021
AOMAOK

Month-end values. Deepest fall: AOM −18.7%, AOK −17.5%.

All the figures

AOMAOK
Annual return (CAGR)+6.4%+5.3%
Total return+206%+153%
Annual volatility7.3%6.1%
Deepest fall (month-end)−18.7%−17.5%
Worst month−6.3%−5.8%
Best month+6.0%+5.5%
Positive months68%68%
Best year2019: +15.6%2019: +13.9%
Worst year2022: −14.5%2022: −14.1%
1-year return+5.6%+3.8%
5 years, a year+4.4%+3.4%
10 years, a year+6.0%+4.8%
Trading currencyUSDUSD

First nine rows: the same 215 months for both funds. Trailing returns: to each fund’s last close.

Year by year

2025
AOM+13.3%
AOK+11.3%
2024
AOM+7.9%
AOK+6.6%
2023
AOM+12.4%
AOK+10.8%
2022
AOM−14.5%
AOK−14.1%
2021
AOM+7.0%
AOK+5.0%
2020
AOM+10.2%
AOK+9.3%
2019
AOM+15.6%
AOK+13.9%
2018
AOM−3.9%
AOK−3.1%
2017
AOM+11.6%
AOK+9.7%
2016
AOM+5.7%
AOK+5.0%
2015
AOM−1.3%
AOK−1.0%
2014
AOM+5.3%
AOK+4.0%
2013
AOM+10.2%
AOK+6.6%
2012
AOM+8.4%
AOK+6.4%
2011
AOM+2.3%
AOK+4.4%
2010
AOM+7.9%
AOK+7.4%
2009
AOM+13.2%
AOK+8.1%

Full calendar years both funds were trading. The higher of the two each year is in bold.

Holding both: half AOM, half AOK

AOM aloneAOK alone50/50
A year on average+6.4%+5.3%+5.9%
Annual volatility7.3%6.1%6.6%
Deepest fall (month-end)−18.7%−17.5%−18.1%
Worst month−6.3%−5.8%−6.1%

With a correlation of 0.97 the mix behaved almost like either fund alone: its volatility of 6.6% sits between the two. Rebalanced to 50/50 every month, before costs.

Questions

Which has returned more, AOM or AOK?

From December 2008 to October 2026, AOM returned +6.4% a year and AOK +5.3% a year, with dividends reinvested. Over rolling 3-year periods AOM did better in 98% of cases. Past returns do not predict future returns.

Which is riskier, AOM or AOK?

Over the same months annual volatility was 7.3% for AOM and 6.1% for AOK; the deepest fall from a month-end high was 18.7% and 17.5%, and the worst single month −6.3% and −5.8%.

How correlated are AOM and AOK?

The correlation of their monthly returns was 0.97: they moved almost in lockstep. Holding both adds little diversification compared with holding one.

What about holding both AOM and AOK?

Half in each, rebalanced every month, returned +5.9% a year over the same period, with 6.6% annual volatility and a deepest month-end fall of 18.1%.

More comparisons

How the figures are calculated

Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.

The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.

Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.